|
🐜
|
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
9 auth.
R. Urbanowicz,
C. P. McClure,
Richard J. P. Brown,
T. Tsoleridis,
Mats A. A. Persson,
T. Krey,
...
W. Irving,
J. Ball,
A. Tarr
|
6 |
2015 |
6
🐜
|
|
🐜
|
Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort
7 auth.
Arwa A. Bagasi,
H. Howson-Wells,
G. Clark,
A. Tarr,
S. Soo,
W. Irving,
...
C. P. McClure
|
5 |
2020 |
5
🐜
|
|
🐬
|
In silico and in vitro interrogation of a widely used HEV RT-qPCR assay for detection of the species Orthohepevirus A.
A. Girón-Callejas,
G. Clark,
W. Irving,
C. P. McClure
|
3 |
2015 |
3
🐬
|
|
🐜
|
Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes
10 auth.
A. Chellapuri,
M. Smitheman,
J. Chappell,
G. Clark,
H. Howson-Wells,
L. Berry,
...
J. Ball,
W. Irving,
A. Tarr,
C. P. McClure
|
2 |
2022 |
2
🐜
|
|
🐜
|
Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses.
12 auth.
P. Jalal,
R. Urbanowicz,
Emma Horncastle,
M. Pathak,
Chun Goddard,
Amanj Saeed,
...
C. P. Mason,
Jonathan K. Ball,
W. Irving,
C. P. McClure,
Barnabas J. King,
A. Tarr
|
1 |
2019 |
1
🐜
|
|
🐜
|
Real-World Outcomes of DAA Treatment and Retreatment in UK-based Patients Infected with HCV Genotypes/Subtypes Endemic in Africa
16 auth.
Elihu Aranday-Cortes,
C. P. McClure,
Chris Davis,
W. Irving,
Kazeem,
Adeboyejo,
Lily Tong,
A. Filipe,
Vattipally B. Sreenu,
Kosh Agarwal,
...
D. Mutimer,
Benjamin Stone,
Matthew E. Cramp,
E. Thomson,
J. Ball,
J. McLauchlan
|
1 |
2021 |
1
🐜
|
